Ultrasound Comes Of Age
Traditionally, there has been little interest among multi-modality imaging companies in having ultrasound technology among their product offerings. But the economic pressures of the current health care environment have forced even the leading imaging companies to take a second look at ultrasound. This turnabout is reflected in Philips's acquisition of ATL Ultrasound Inc., the leader in digital ultrasound.
You may also be interested in...
Adding non-transfusion-dependent anemia patients to the Reblozyl label is a key strategy for the product, which BMS expects to reach $4bn in annual sales.
Biogen has warned that uptake for its newly approved Alzheimer’s therapy will be slow in the beginning and doctors confirm it will take time to figure which patients can and should be treated.
Public Company Edition: The pace of US initial public offerings slowed a bit in April and May but could ramp back up in June as biopharma investor sentiment rebounds. Also, drug developers continue to go public via SPAC mergers, most recently Valo Health with a $2.8bn post-deal valuation.